Biology of Angiogenesis and Invasion in Glioma

Matthew C. Tate, Manish K. Aghi*

*Corresponding author for this work

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Treatment of adult brain tumors, in particular glioblastoma, remains a significant clinical challenge, despite modest advances in surgical technique, radiation, and chemotherapeutics. The formation of abnormal, dysfunctional tumor vasculature and glioma cell invasion along white matter tracts are believed to be major components of the inability to treat these tumors effectively. Recent insight into the fundamental processes governing glioma angiogenesis and invasion provide a renewed hope for development of novel strategies aimed at reducing the morbidity of this uniformly fatal disease. In this review, we discuss background biology of the blood brain barrier and its pertinence to blood vessel formation and tumor invasion. We will then focus our attention on the biology of glioma angiogenesis and invasion, and the key mediators of these processes. Last, we will briefly discuss recent and ongoing clinical trials targeting mediators of angiogenesis or invasion in glioma patients. The findings provide a renewed hope for those endeavoring to improve treatment of patients with glioma by providing a novel set of rational targets for translational drug discovery.

Original languageEnglish (US)
Pages (from-to)447-457
Number of pages11
JournalNeurotherapeutics
Volume6
Issue number3
DOIs
StatePublished - Jul 1 2009

Fingerprint

Glioma
Vascular Tissue Neoplasms
Drug Discovery
Glioblastoma
Blood-Brain Barrier
Brain Neoplasms
Neoplasms
Clinical Trials
Radiation
Morbidity
Therapeutics

Keywords

  • Angiogenesis
  • VEGF
  • extracellular matrix
  • glioblastoma
  • invasion

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Tate, Matthew C. ; Aghi, Manish K. / Biology of Angiogenesis and Invasion in Glioma. In: Neurotherapeutics. 2009 ; Vol. 6, No. 3. pp. 447-457.
@article{fd072150d75f4fa3b5584a17662ef1cf,
title = "Biology of Angiogenesis and Invasion in Glioma",
abstract = "Treatment of adult brain tumors, in particular glioblastoma, remains a significant clinical challenge, despite modest advances in surgical technique, radiation, and chemotherapeutics. The formation of abnormal, dysfunctional tumor vasculature and glioma cell invasion along white matter tracts are believed to be major components of the inability to treat these tumors effectively. Recent insight into the fundamental processes governing glioma angiogenesis and invasion provide a renewed hope for development of novel strategies aimed at reducing the morbidity of this uniformly fatal disease. In this review, we discuss background biology of the blood brain barrier and its pertinence to blood vessel formation and tumor invasion. We will then focus our attention on the biology of glioma angiogenesis and invasion, and the key mediators of these processes. Last, we will briefly discuss recent and ongoing clinical trials targeting mediators of angiogenesis or invasion in glioma patients. The findings provide a renewed hope for those endeavoring to improve treatment of patients with glioma by providing a novel set of rational targets for translational drug discovery.",
keywords = "Angiogenesis, VEGF, extracellular matrix, glioblastoma, invasion",
author = "Tate, {Matthew C.} and Aghi, {Manish K.}",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.nurt.2009.04.001",
language = "English (US)",
volume = "6",
pages = "447--457",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "3",

}

Biology of Angiogenesis and Invasion in Glioma. / Tate, Matthew C.; Aghi, Manish K.

In: Neurotherapeutics, Vol. 6, No. 3, 01.07.2009, p. 447-457.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biology of Angiogenesis and Invasion in Glioma

AU - Tate, Matthew C.

AU - Aghi, Manish K.

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Treatment of adult brain tumors, in particular glioblastoma, remains a significant clinical challenge, despite modest advances in surgical technique, radiation, and chemotherapeutics. The formation of abnormal, dysfunctional tumor vasculature and glioma cell invasion along white matter tracts are believed to be major components of the inability to treat these tumors effectively. Recent insight into the fundamental processes governing glioma angiogenesis and invasion provide a renewed hope for development of novel strategies aimed at reducing the morbidity of this uniformly fatal disease. In this review, we discuss background biology of the blood brain barrier and its pertinence to blood vessel formation and tumor invasion. We will then focus our attention on the biology of glioma angiogenesis and invasion, and the key mediators of these processes. Last, we will briefly discuss recent and ongoing clinical trials targeting mediators of angiogenesis or invasion in glioma patients. The findings provide a renewed hope for those endeavoring to improve treatment of patients with glioma by providing a novel set of rational targets for translational drug discovery.

AB - Treatment of adult brain tumors, in particular glioblastoma, remains a significant clinical challenge, despite modest advances in surgical technique, radiation, and chemotherapeutics. The formation of abnormal, dysfunctional tumor vasculature and glioma cell invasion along white matter tracts are believed to be major components of the inability to treat these tumors effectively. Recent insight into the fundamental processes governing glioma angiogenesis and invasion provide a renewed hope for development of novel strategies aimed at reducing the morbidity of this uniformly fatal disease. In this review, we discuss background biology of the blood brain barrier and its pertinence to blood vessel formation and tumor invasion. We will then focus our attention on the biology of glioma angiogenesis and invasion, and the key mediators of these processes. Last, we will briefly discuss recent and ongoing clinical trials targeting mediators of angiogenesis or invasion in glioma patients. The findings provide a renewed hope for those endeavoring to improve treatment of patients with glioma by providing a novel set of rational targets for translational drug discovery.

KW - Angiogenesis

KW - VEGF

KW - extracellular matrix

KW - glioblastoma

KW - invasion

UR - http://www.scopus.com/inward/record.url?scp=67649120009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649120009&partnerID=8YFLogxK

U2 - 10.1016/j.nurt.2009.04.001

DO - 10.1016/j.nurt.2009.04.001

M3 - Article

VL - 6

SP - 447

EP - 457

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 3

ER -